Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Non-Current Liabilities (2016 - 2025)

Marimed has reported Total Non-Current Liabilities over the past 15 years, most recently at $137.8 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 6.56% to $137.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.8 million through Dec 2025, up 6.56% year-over-year, with the annual reading at $137.8 million for FY2025, 6.56% up from the prior year.
  • Total Non-Current Liabilities was $137.8 million for Q4 2025 at Marimed, up from $136.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $137.8 million in Q4 2025 and troughed at $37.5 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $89.2 million (2023), against an average of $89.3 million.
  • Year-over-year, Total Non-Current Liabilities plummeted 36.32% in 2021 and then skyrocketed 87.69% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $49.1 million in 2021, then rose by 16.27% to $57.1 million in 2022, then skyrocketed by 87.69% to $107.1 million in 2023, then increased by 20.76% to $129.3 million in 2024, then rose by 6.56% to $137.8 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Total Non-Current Liabilities are $137.8 million (Q4 2025), $136.5 million (Q3 2025), and $131.1 million (Q2 2025).